This HCA Healthcare Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Raymond James analyst John Ransom downgraded the rating for HCA Healthcare, Inc. HCA from Outperform to Market Perform. HCA Healthcare shares closed at $332.24 on Thursday. See how other analysts view this stock.
JMP Securities analyst Matthew Carletti downgraded the rating for Root, Inc. ROOT from Market Outperform to Market Perform. Root shares closed at $109.40 on Thursday. See how other analysts view this stock.
Needham analyst Mike Matson downgraded TransMedics Group, Inc TMDX from Buy to Hold and maintained the price target of $109. TransMedics shares closed at $79.34 on Thursday. See how other analysts view this stock.
Keybanc analyst Steve Barger downgraded the rating for The Timken Company TKR from Overweight to Sector Weight. Timken shares closed at $75.22 on Thursday. See how other analysts view this stock.
B. Riley Securities analyst Alex Rygiel downgraded Atkore Inc. ATKR from Buy to Neutral and lowered the price target from $135 to $84. Atkore shares closed at $85.14 on Thursday. See how other analysts view this stock.